Implications of ABCG2 Expression on Irinotecan Treatment of Colorectal Cancer Patients: A Review

Background: One of the main chemotherapeutic drugs used on a routine basis in patients with metastatic colorectal cancer ((m)CRC) is the topoisomerase-1 inhibitor, irinotecan. However, its usefulness is limited by the pre-existing or inevitable development of resistance. The ATP-binding cassette (AB...

Descripción completa

Detalles Bibliográficos
Autores principales: Nielsen, Dorte Lisbet, Palshof, Jesper Andreas, Brünner, Nils, Stenvang, Jan, Viuff, Birgitte Martine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618575/
https://www.ncbi.nlm.nih.gov/pubmed/28880238
http://dx.doi.org/10.3390/ijms18091926

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618575/
https://www.ncbi.nlm.nih.gov/pubmed/28880238
http://dx.doi.org/10.3390/ijms18091926

Ejemplares similares